142 related articles for article (PubMed ID: 17325858)
1. CD5 does not regulate the signaling triggered through BCR in B cells from a subset of B-CLL patients.
Perez-Chacon G; Vargas JA; Jorda J; Alvarez N; Martin-Donaire T; Rosado S; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
Leuk Lymphoma; 2007 Jan; 48(1):147-57. PubMed ID: 17325858
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity.
Ochi H; Watanabe T
Int Immunol; 2000 Oct; 12(10):1417-23. PubMed ID: 11007759
[TBL] [Abstract][Full Text] [Related]
4. Natural phosphorylation of CD5 in chronic lymphocytic leukemia B cells and analysis of CD5-regulated genes in a B cell line suggest a role for CD5 in malignant phenotype.
Gary-Gouy H; Sainz-Perez A; Marteau JB; Marfaing-Koka A; Delic J; Merle-Beral H; Galanaud P; Dalloul A
J Immunol; 2007 Oct; 179(7):4335-44. PubMed ID: 17878328
[TBL] [Abstract][Full Text] [Related]
5. CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes.
Garaud S; Taher TE; Debant M; Burgos M; Melayah S; Berthou C; Parikh K; Pers JO; Luque-Paz D; Chiocchia G; Peppelenbosch M; Isenberg DA; Youinou P; Mignen O; Renaudineau Y; Mageed RA
Cell Mol Immunol; 2018 Feb; 15(2):158-170. PubMed ID: 27499044
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes in chronic lymphocytic leukaemia associated with expression of CD5, a negative regulator of B-cell receptor signalling.
Friedman DR; Guadalupe E; Volkheimer A; Moore JO; Weinberg JB
Br J Haematol; 2018 Dec; 183(5):747-754. PubMed ID: 30407619
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells.
Gobessi S; Laurenti L; Longo PG; Carsetti L; Berno V; Sica S; Leone G; Efremov DG
Leukemia; 2009 Apr; 23(4):686-97. PubMed ID: 19092849
[TBL] [Abstract][Full Text] [Related]
8. Survival of leukemic B cells promoted by engagement of the antigen receptor.
Bernal A; Pastore RD; Asgary Z; Keller SA; Cesarman E; Liou HC; Schattner EJ
Blood; 2001 Nov; 98(10):3050-7. PubMed ID: 11698290
[TBL] [Abstract][Full Text] [Related]
9. Role of CD5 in growth regulation of B-1 cells.
Bondada S; Bikah G; Robertson DA; Sen G
Curr Top Microbiol Immunol; 2000; 252():141-9. PubMed ID: 11125471
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells.
Sen G; Bikah G; Venkataraman C; Bondada S
Eur J Immunol; 1999 Oct; 29(10):3319-28. PubMed ID: 10540344
[TBL] [Abstract][Full Text] [Related]
11. Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells.
Renaudineau Y; Nédellec S; Berthou C; Lydyard PM; Youinou P; Pers JO
Leukemia; 2005 Feb; 19(2):223-9. PubMed ID: 15618965
[TBL] [Abstract][Full Text] [Related]
12. CD5-negative regulation of B cell receptor signaling pathways originates from tyrosine residue Y429 outside an immunoreceptor tyrosine-based inhibitory motif.
Gary-Gouy H; Harriague J; Dalloul A; Donnadieu E; Bismuth G
J Immunol; 2002 Jan; 168(1):232-9. PubMed ID: 11751967
[TBL] [Abstract][Full Text] [Related]
13. Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones.
Bashford-Rogers RJ; Palser AL; Hodkinson C; Baxter J; Follows GA; Vassiliou GS; Kellam P
Exp Hematol; 2017 Feb; 46():31-37.e10. PubMed ID: 27693386
[TBL] [Abstract][Full Text] [Related]
14. Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells.
Tibaldi E; Brunati AM; Zonta F; Frezzato F; Gattazzo C; Zambello R; Gringeri E; Semenzato G; Pagano MA; Trentin L
Leukemia; 2011 Nov; 25(11):1768-81. PubMed ID: 21701493
[TBL] [Abstract][Full Text] [Related]
15. CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC.
Perez-Chacon G; Vargas JA; Jorda J; Morado M; Rosado S; Martin-Donaire T; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
Leuk Res; 2007 Feb; 31(2):183-93. PubMed ID: 16725198
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.
Cui B; Chen L; Zhang S; Mraz M; Fecteau JF; Yu J; Ghia EM; Zhang L; Bao L; Rassenti LZ; Messer K; Calin GA; Croce CM; Kipps TJ
Blood; 2014 Jul; 124(4):546-54. PubMed ID: 24914134
[TBL] [Abstract][Full Text] [Related]
17. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
[TBL] [Abstract][Full Text] [Related]
18. Functional studies of chronic lymphocytic leukemia B cells expressing β
Uzonyi B; Mácsik-Valent B; Lukácsi S; Kiss R; Török K; Kremlitzka M; Bajtay Z; Demeter J; Bödör C; Erdei A
Immunol Lett; 2017 Sep; 189():73-81. PubMed ID: 28577901
[TBL] [Abstract][Full Text] [Related]
19. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor.
Chiorazzi N; Ferrarini M
Annu Rev Immunol; 2003; 21():841-94. PubMed ID: 12615894
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of Ikaros expression in B-1 cells: New insights in the malignant transformation to chronic lymphocytic leukemia.
Oliveira VC; Lacerda MP; Moraes BBM; Gomes CP; Maricato JT; Souza OF; Schenkman S; Pesquero JB; Moretti NS; Rodrigues CA; Popi AF
J Leukoc Biol; 2019 Sep; 106(3):581-594. PubMed ID: 31299112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
